Drug Product Partner
Accelerate Your Drug Program to Commercial Product Supply
Quotient Sciences recognise that speed is crucial, but it should never come at the expense of drug product quality.
We are committed to accelerating promising molecules into quality drug products from proof-of-concept to commercial launch and supply.
We offer our customers the service to manufacture a range of simple to complex dosage forms. We have a 30-year track record of working with higher-value products that may require lower batch sizes in the market. Those products include oncology therapies, orphan drugs/rare diseases, and pediatric indications.
Drug Product Partner
At Quotient Sciences we believe in being the flexible partner of choice in getting your molecule through to viable drug product and commercial manufacture.
We recognise that our customers face a variety of business challenges, especially when it comes to new drug development and clinical trial manufacturing.
We provide integrated programs such as our Translational Pharmaceutics® drug accelerator platform alongside more tailored solutions to meet your unique pharmaceutical drug product development and clinical trial material manufacturing outsourcing requirements.
Contact our experts
Quotient Sciences can help address the most critical challenges in drug product programs. Contact us today to learn how we can help accelerate your program and take your molecule to cure, fast.
Molecule to cure. Fast.
-
Accelerating TimelinesAccelerate your path to the clinic with Charles River & Quotient SciencesIntegrated strategies for accelerating from discovery to IND. Introducing the Charles River and Quotient Sciences Collaboration.
-
Integrated ProgramsTranslational Pharmaceutics®Quotient Sciences' own Translational Pharmaceutics® solution innovates the way you design and implement your drug development program.